home / stock / pyxs / pyxs news


PYXS News and Press, Pyxis Oncology Inc. From 03/08/24

Stock Information

Company Name: Pyxis Oncology Inc.
Stock Symbol: PYXS
Market: NASDAQ
Website: pyxisoncology.com

Menu

PYXS PYXS Quote PYXS Short PYXS News PYXS Articles PYXS Message Board
Get PYXS Alerts

News, Short Squeeze, Breakout and More Instantly...

PYXS - GENI, EA, AROC, PYXS, ASO showing five-day downward plunge

2024-03-08 09:47:01 ET Genius Sports Limited (GENI) GENI is trading DOWN for the last 4 days, and it at trading at $6.26 with volume of 1,145,622 and a one day change of $-0.03 (-0.54%). Genius Sports Limited has a 52-week low of 3.55 and a 52-week high of $8.45. The business's 50-d...

PYXS - Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024

BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in...

PYXS - Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting

PYX-201, an EDB+FN-specific tumor stroma-targeting ADC, demonstrates potent anti-tumor efficacy across multiple human cancers in PDX tumor models The PYX-201 target EDB+FN is found overexpressed across multiple human solid tumor types BOSTON, March 05, 2024 (GLOBE NEWSWIRE) -- Pyx...

PYXS - Pyxis Oncology Announces $50 Million Private Placement

BOSTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that it has agreed to sell 8,849,371 shares of its common stock a...

PYXS - FIVN, HLIT and SANM are among after hour movers

2024-01-29 16:59:37 ET Gainers: Sanmina Corporation ( SANM ) +15% . Woodward ( WWD ) +7% . F5  ( FFIV ) +7% . Super Micro Computer ( SMCI ) +6% . Alpine Immune Sciences ( ALPN ) +4% . Losers: J-Long Group  ( J...

PYXS - PYXS, OXY, SMCI, DVN, LBRT showing five-day upward surge

2024-01-26 09:45:09 ET Pyxis Oncology Inc. (PYXS) PYXS is trading UP for the last 5 days, and it at trading at $3.19 with volume of 3,663,280 and a one day change of $0.03 (0.92%). Pyxis Oncology Inc. has a 52-week low of 1.35 and a 52-week high of $6.92. The business's 50-day movin...

PYXS - NOVA, BGC and EOSE are among pre market gainers

2024-01-23 08:24:49 ET Rail Vision  ( RVSN ) +29% . TKO Group Holdings  ( TKO ) +19% . vTv Therapeutics  ( VTVT ) +18% . Bit Brother  ( BETS ) +13% . Jeffs Brands  ( JFBR ) +10% . Rumble  ( RUM )...

PYXS - Pyxis Oncology: Making A Bold Acquisition Move, But It's Not A Convincing Thesis

2024-01-17 20:15:07 ET Summary Pyxis Oncology is a biotech company focused on developing immunotherapies for cancer treatment. Their most advanced pipeline project is sotigalimab, a CD40 agonist, which has shown promising results in melanoma and liposarcoma. The company has en...

PYXS - CALM, GLYC and RBBN are among after hour movers

2024-01-04 16:19:31 ET Gainers: Molecular Partners ( MOLN ) +14% . Sutro Biopharma ( STRO ) +9% . Ribbon Communications ( RBBN ) +7% . Resources Connection ( RGP ) +7% . Pyxis Oncology ( PYXS ) +6% . Losers: 89bio ( ETN...

PYXS - Bluebird bio, Rockwell Medical among healthcare movers

2023-12-08 10:00:17 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Bluebird bio, ...

Previous 10 Next 10